OR

Browse By

Safety and tolerability of Trimetazidine for the treatment of ALS (2020–2025)

Grant type:
Cure for MND Foundation - Drug Development Grants
Researchers:

  • Associate Professor Shyuan Ngo

    Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
    Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology

  • Associate Professor Frederik Steyn

    Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
    Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
Funded by:
Cure for MND Foundation